BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7714788)

  • 1. Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects.
    Rush CR; Sullivan JT; Griffiths RR
    J Pharmacol Exp Ther; 1995 Apr; 273(1):351-8. PubMed ID: 7714788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine alters the effects of intravenous cocaine in humans.
    Walsh SL; Preston KL; Sullivan JT; Fromme R; Bigelow GE
    J Clin Psychopharmacol; 1994 Dec; 14(6):396-407. PubMed ID: 7884020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of placebo awareness on stimulant drug response in a double-blind trial.
    Nash JM; Holroyd KA; Rokicki LA; Kvaal S; Penzien DB
    Psychopharmacology (Berl); 2002 May; 161(3):213-21. PubMed ID: 12021824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
    Preston KL; Sullivan JT; Berger P; Bigelow GE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):296-307. PubMed ID: 8229755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
    Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
    Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone.
    Foltin RW; Christiansen I; Levin FR; Fischman MW
    J Pharmacol Exp Ther; 1995 Oct; 275(1):38-47. PubMed ID: 7562574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cocaine and caffeine alone and in combination on cardiovascular performance: an experimental hemodynamic and coronary flow reserve study in a canine model.
    Mehta MC; Jain AC; Billie M
    Int J Cardiol; 2004 Nov; 97(2):225-32. PubMed ID: 15458688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects.
    Foltin RW; Fischman MW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):247-61. PubMed ID: 2019989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of L-theanine, caffeine and their combination on cognition and mood.
    Haskell CF; Kennedy DO; Milne AL; Wesnes KA; Scholey AB
    Biol Psychol; 2008 Feb; 77(2):113-22. PubMed ID: 18006208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
    Preston KL; Sullivan JT; Strain EC; Bigelow GE
    J Pharmacol Exp Ther; 1992 Jul; 262(1):279-91. PubMed ID: 1625204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.
    Henningfield JE; Miyasato K; Jasinski DR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):1-12. PubMed ID: 4009494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers.
    Smith A; Sutherland D; Christopher G
    J Psychopharmacol; 2005 Nov; 19(6):620-6. PubMed ID: 16272184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of caffeine on performance and mood depend on the level of caffeine abstinence.
    Yeomans MR; Ripley T; Davies LH; Rusted JM; Rogers PJ
    Psychopharmacology (Berl); 2002 Nov; 164(3):241-9. PubMed ID: 12424547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1987 Mar; 240(3):900-10. PubMed ID: 3559982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.